瑞舒伐他汀的药理分析及抗动脉粥样硬化的临床应用价值

Rui shu laval statin pharmacological analysis and the clinical value of resistance to atherosclerosis

目的:分析瑞舒伐他汀药理作用及其治疗抗动脉粥样硬化临床效果。方法:按照随机综合序贯法将本院2015年2月—2016年6月接诊动脉粥样硬化患者90例分为对照组和观察组,两组分别采用阿司匹林治疗及瑞舒伐他汀治疗,对比两组不同治疗效果。结果:两组治疗前颈动脉内膜中层厚度IMT、总胆固醇TC、三酰甘油TG、低密度脂蛋白胆固醇LDL-C比较,差异无统计学意义(P>0.05);观察组治疗后以上指标水平均明显较低(P<0.05)。结论:瑞舒伐他汀用于治疗抗动脉粥样硬化,临床价值突出,有助于显著改善患者动脉粥样硬化情况。

Objective To analyze rui shu cutting treatment resistant pharmacological action and clinical effect of atherosclerosis.Methods According to the random comprehensive sequential method will be in our hospital in February2015-June 2016 accepts atherosclerosis patients 90 cases were divided into control group and observation group, two groups, respectively, using aspirin therapy and shu cut statin therapy, compared two groups of different therapeutic effect.Results The two groups before treatment of carotid intima-media thickness IMT three acyl glycerin, total cholesterol(TC,TG, LDL cholesterol, LDL-C, there was no statistically significant difference(P > 0.05);Observation group above index levels were significantly lower after treatment(P < 0.05).Conclusion Rui shu laval statin treatment for resistance to atherosclerosis,clinical value is outstanding, help to atherosclerosis in patients with significant improvement.